unknown
Stage
1
Investors
About
Biobeat develops FDA-cleared, cuffless, wireless, and non-invasive medical-grade chest patch devices for 24-hour ambulatory blood pressure monitoring to improve hypertension diagnosis and management.
Explore Biobeat's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.